#Dupixent

top of page

GRbusiness_logo-find latest business updates and growth reports across industriespng

Latest Updates
Contact
T & C
More

Use tab to navigate through the menu items.

Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe a

Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe a

Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe a

Sanofi Healthcare India Pvt. Ltd. today announced that it has received marketing authorization for Dupixent® (dupilumab), the first...

Jul 11, 20233 min read

RND Coupon Banner Festival30.png

30% SHOPPING DISCOUNT

follow our tweets

©2024 by Growth Reports. Managed by Zerodot Plus

bottom of page